IRCT201212034333N2已完成未知
Comparison of clinical results of two pharmaceutical products of Riboflavin in corneal collagen Cross-Linking for keratoconus
oor Eye Hospital0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 15 years 至 35 years（—）
- 性别
- All
入选标准
- •The inclusion criterion is the clinical diagnosis of progressive keratoconus with paraclinical confirmation. The criteria of progressive keratoconus is an increase of at least 1D in maximum keratometry, astigmatism, or manifest refraction, or loss of 2 best corrected visual acuity (BCVA) lines or more in the past 12 months. Patients aged 15-35 years old with keratometry less than 55D and a central corneal thickness less than 400 µ will be selected for the study. Patients with other ocular diseases or a history of ocular surgery will be excluded from the study. Participants discontinue the use of the hard and soft contact lens 3 weeks and 3 days prior to the surgery, respectively.
排除标准
- 未提供
研究者
相似试验
已完成
2 期
Comparative pharmaceutico-analytical study of two types of kanta loha bhasmas and their clinical efficacy in the management of type 2 diabetesCTRI/2020/05/025358Institute for Post Graduate Teaching and Research in Ayurveda60
已完成
2 期
Comparison of cyclosporine and tacrolimus in two immunosuppressive drug regimen in patients undergoing kidney transplantatiosurvival of transplanted kidney.Kidney transplant failure and rejectionIRCT201105166500N1Kermanshah University of Medical Scienes and Health Services200
已完成
不适用
The effects of Pharmacological and Non-pharmacological methods on the Radial Artery Spasm in Radial AngiographyIRCT2017071324312N2Vice Chancellor for Research, Baqiyatallah University of Medical Sciences90
招募中
不适用
Treatment of skeletal class II malocclusion using two different fixed functional applianceCTRI/2019/07/020050Director General Armed Forces Medical Services
已完成
不适用
Treatment of growing individuals with small lower jaw using appropriate fixed functional appliances.CTRI/2021/01/030399Director General Armed Forces Medical Services30